| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |